Nanoformulation-based medicines for the treatment of reactive oxygen species-induced diseases: A review. Nanofabrication, [S. l.], v. 10, 2025. DOI: 10.37819/nanofab.10.2055. Disponível em: https://eaapublishing.org/journals/index.php/nanofab/article/view/2055. Acesso em: 15 dec. 2025.